ADICON Adds COO Wang Legang to Board as Executive Director

ADICON Holdings Limited ( (HK:9860) ) has shared an announcement.

ADICON Holdings Limited has appointed chief operating officer and general manager Wang Legang as an executive director with effect from 13 February 2026, further consolidating its leadership team with a seasoned healthcare and pharmaceutical executive. Wang, a 45-year-old clinical pharmacy graduate with EMBA training, brings extensive experience from major pharmaceutical multinationals and digital health platforms, and his three‑year service agreement aligns his role in operations with board‑level oversight, signaling a tighter integration of management and governance that may support the company’s growth and digital transformation strategy.

Under the terms of his appointment, Wang will not receive a separate director’s fee, with his overall emoluments set by the board based on his qualifications, responsibilities and prevailing market conditions, and he will remain subject to retirement by rotation and re‑election at shareholder meetings. The company emphasized that Wang holds no interests in its shares, has no disclosed relationships with existing directors or major shareholders, and meets Hong Kong listing rule requirements, suggesting a focus on regulatory compliance and independent governance as it strengthens its board composition.

The most recent analyst rating on (HK:9860) stock is a Buy with a HK$8.60 price target. To see the full list of analyst forecasts on ADICON Holdings Limited stock, see the HK:9860 Stock Forecast page.

More about ADICON Holdings Limited

ADICON Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare sector, with a focus on medical and diagnostic services supported by business management and digital transformation capabilities. The group relies on experienced executives with backgrounds in pharmaceuticals, digital health and interactive medicine to drive operational efficiency and market expansion.

Average Trading Volume: 3,982,983

Technical Sentiment Signal: Sell

Current Market Cap: HK$3.65B

For a thorough assessment of 9860 stock, go to TipRanks’ Stock Analysis page.